https://www.selleckchem.com/pr....oducts/capsazepine.h
ial regression. To describe strategy and results of fertility preservation (FP) in patients with malignant and borderline ovarian tumors. Consecutive cohort study of 43 women with malignant or borderline ovarian tumors who underwent FP between February 2013 and July 2019. The study was conducted in national expert center in Tenon University Hospital, Sorbonne University French ESGO-certified ovarian cancer center and pregnancy-associated cancer network (CALG). Main outcome measure was FP technique proposed by multidisciplinary commi
Like
Comment
Share
